ARTICLE | Clinical News
Glassia regulatory update
July 12, 2010 7:00 AM UTC
FDA approved a BLA from Kamada for Glassia to treat alpha 1-antitrypsin (AAT) deficiency. Glassia is an intravenous formulation of AAT. ...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
FDA approved a BLA from Kamada for Glassia to treat alpha 1-antitrypsin (AAT) deficiency. Glassia is an intravenous formulation of AAT. ...